InvestorsHub Logo
Followers 2
Posts 57
Boards Moderated 0
Alias Born 07/03/2017

Re: None

Wednesday, 08/02/2017 12:30:00 AM

Wednesday, August 02, 2017 12:30:00 AM

Post# of 203911
OWCP + Mediq to Sell in Germany - EMINENT

PARTNERSHIP AGREEMENT COMING FOR SALES.

OWCP + Mediq Collaborate to Introduce Cannabinoid-based Psoriasis Cream in Germany
https://psoriasisnewstoday.com/2017/06/01/owcp-and-mediq-collaborate-to-introduce-cannabinoid-based-psoriasis-cream-in-germany/

We’re looking forward to initiating our efforts on behalf of OWCP in Europe, starting in our home market of Germany,” Jan Wende, managing director of mediq, said in a press release. “Since German laws and regulations allow non-smokable forms of medical cannabis, we believe that OWCP’s proprietary cannabinoid-based topical psoriasis cream is the right product at the right time.


“Furthermore, Germany is the largest European healthcare market and therefore offers the perfect platform to gain local evidence and roll out the concept into other European countries,” Wende added. “Our initial focus for OWCP is on the German market, however, we’re excited about the long-term opportunities throughout Europe, a market with a population of over 740 million.


Alon Sinai, managing director of One World Cannabis, said the German market is a great opportunity for OWCP.

Germany, with its population of over 81 million and a gross domestic product of over US $3.36 trillion, is the largest economy in Europe,” Sinai said. “Also potentially beneficial to OWCP is Germany’s recent medical cannabis legislation, which currently limits the usage of smokable products, and which also provides for reimbursement for medical cannabis by the country’s healthcare system.”